SCHEMBL4817706

SCHEMBL4817706

CC1(C)C[CH]N(C(=O)Cc2cccc(Oc3ccccc3)c2)C1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.56
BRS3 P32247 1/20 0.43
NAAA Q02083 1/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CCR8 P51685 4/20 0.42
TDP1 Q9NUW8 3/20 0.42
FFAR1 O14842 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
PTGES O14684 1/20 0.41
ADRA2A P08913 1/20 0.41
CNR1 P21554 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4819758 0.84 ALDH1A1 (0.50) KDM4EALDH1A1LMNAGAASMN1; SMN2
SCHEMBL4817713 0.81 FAAH (0.56) FAAHBRS3KDM4EALDH1A1LMNA
SCHEMBL4817700 0.81 FAAH (0.56) FAAHBRS3KDM4EALDH1A1LMNA
SCHEMBL4814895 0.77 NAAA (0.50) FAAHNAAAALDH1A1LMNAGAA
SCHEMBL10706227 0.72 FFAR1 (0.54) FAAHTDP1FFAR1PTGES
SCHEMBL415441 0.72 FFAR1 (0.68) FAAHTDP1FFAR1
SCHEMBL19612661 0.72 FAAH (1.00) FAAHNAAAKDM4EALDH1A1
SCHEMBL31618736 0.71 FFAR1 (0.52) FAAHKDM4EALDH1A1CCR8TDP1
Hydrochloric Acid SCHEMBL8694026 0.71 FFAR1 (0.67) FAAHTDP1FFAR1
SCHEMBL4817869 0.71 HSD11B1 (0.47) ALDH1A1LMNAGAASMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7402606-B2 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss SMITHKLINE BEECHAM CORPORATION (US) 2008-07-22 US claimed
EP-1494663-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SmithKline Beecham Corporation (US) 2005-01-12 EP claimed
WO-2003086385-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SMITHKLINE BEECHAM CORPORATION (US) 2003-10-23 WO claimed
US-7402606-B2 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss SMITHKLINE BEECHAM CORPORATION (US) 2008-07-22 US disclosed
EP-1494663-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SmithKline Beecham Corporation (US) 2005-01-12 EP disclosed
WO-2003086385-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SMITHKLINE BEECHAM CORPORATION (US) 2003-10-23 WO disclosed